Related Experiment Video
Updated: Oct 1, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Bioavailability in the human eye of a fixed combination of latanoprost and timolol compared to monotherapy
Berit Calissendorff1, Birgitta Sjöquist, Gunilla Högberg
1Department of Ophthalmology, St. Eriks Eye Hospital, Stockholm, Sweden.
Abstract:
The ocular pharmacokinetics of a single topical administration of a fixed combination (FC) of latanoprost 0.005% and timolol 0.5% was compared to the monotherapies of latanoprost and timolol in cataract surgery patients. The absorption rate of latanoprost and timolol into the aqueous humor was similar after administration of the FC compared to the two drugs given separately. The aqueous humor concentration of the acid of latanoprost tended to be higher 1-4 hours after administration of FC compared to latanoprost monotherapy. This resulted in an increased AUC. The Tmax and elimination half-life of both latanoprost and timolol were similar after administration of either FC or the two drugs given as monotherapy. Latanoprost did not have any influence on the ocular pharmacokinetics of timolol. The bioavailability of latanoprost and timolol into human aqueous humor, after FC, was at least as good as for the two drugs administered separately.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Bioequivalence: Overview
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Measurement of Bioavailability: Pharmacodynamic Methods